Your publication plan exists on paper only
Your publication plan exists on paper. But manuscripts stall, authors don’t respond, and journal submission timelines slip. By the time articles are published, they’re no longer strategically useful.
Why this happens
Publications stall at the operational level
Most publication delays aren’t scientific — they’re operational. Authors don’t respond to emails. Internal review cycles take months. The medical writer doesn’t understand the therapeutic area.
The strategic cost is real. A manuscript that was supposed to support an HTA submission publishes 8 months late. A congress abstract misses the deadline. A systematic review becomes outdated before submission.
Publication plans look great in January. By December, half the deliverables are carried over to next year — with the same bottlenecks.
“Our publication plan had 12 manuscripts. By year-end, 3 were published. The rest were still ‘in progress’ — for the second year in a row.”
— Medical Manager, East Europe, Respiratory
Sound familiar?
Typical situations we hear
01
Manuscript stuck in author review
The draft has been with the lead author for 3 months. Gentle reminders produce no response. The journal deadline is approaching.
02
Internal review bottleneck
The manuscript passed scientific review. But legal-medical-regulatory review adds 8 weeks. Every comment triggers a new cycle.
03
Medical writer turnover
Your CRO changed the assigned writer mid-project. The new writer doesn’t know the TA. Draft quality drops. Revision cycles multiply.
04
Publication plan behind schedule
Six months into the year, only 2 of 10 planned publications are on track. No clear path to recovery.
What breaks without intervention
The cost of doing nothing
Strategic publications miss their window
Manuscripts meant to support HTA submissions or launch narratives publish too late to influence key decisions.
KOL engagement weakens
Authors who committed lose patience with delays. Re-engaging them for future projects becomes harder.
Competitive narrative gap
Competitors publish on the same topic first. Your team’s publications become ‘me too’ rather than thought leadership.
How MAG solves it
From stalled drafts to submitted manuscripts
1
Publication audit & triage
We review your publication plan, identify stalled projects, and prioritize based on strategic importance and recoverability.
2
Author re-engagement
We systematically re-engage authors with clear timelines, structured review templates, and milestone-based coordination.
3
Expert medical writing
Our writers have deep TA expertise. We produce publication-grade manuscripts requiring minimal author revision.
4
Internal review management
We coordinate with legal-medical-regulatory teams to streamline review — managing comments, tracking revisions, preventing re-reviews.
5
Journal submission & tracking
We handle journal selection, formatting, submission, reviewer responses, and proofs. Every publication has a defined endpoint.
Services we use to solve this
What you get
Typical deliverables
Publication-ready manuscript
Congress abstract
Scientific poster
Author review tracker
Internal review coordination
Journal submission package
Publication timeline dashboard
Real work. Measurable outcomes.
Related case studies
Systematic review and meta-analysis: epidemiology of invasive mycosis in immunocompromised patients
✓ Published in peer-reviewed journal within agreed timeline
Read case study →
National epidemiological study in rare disease: protocol through ethics to peer-reviewed publication
✓ Study published in peer-reviewed journal within 18-month timeline
Read case study →
Frequently asked
Common questions
Can you take over a stalled manuscript?
Yes. We frequently rescue manuscripts that have been ‘in progress’ for months. We audit the current state and create a clear path to submission.
How do you manage unresponsive authors?
We use structured outreach with clear deadlines, simplified review templates, and milestone-based coordination.
What therapeutic areas do your writers cover?
Our medical writers have expertise in oncology, immunology, cardiology, endocrinology, rare diseases, infectious diseases, and neurology.
Do you handle GPP3/ICMJE compliance?
Absolutely. All publications follow Good Publication Practice (GPP2024), ICMJE criteria, and relevant journal guidelines.
Still have questions about publication support?
Book a 20-minute scoping call. We’ll review your situation and suggest the fastest path forward.
Book a scoping call →
Browse all services
Publications
falling behind?
falling behind?
Share your publication plan — we’ll identify which projects can be rescued and propose a realistic recovery timeline.
AI infrastructure
AI-powered.
Expert-validated.
We built AI workflows into our daily practice — not as a marketing claim, but as the infrastructure that lets our medical experts deliver faster without cutting corners.
Research
Structured PubMed queries with narrative or table outputs
Monitoring
Weekly literature digests by drug, target, or topic
AI-Enhanced EDC
Advisory board transcription + structured AI summary
Fact-Checker
Claim verification against your source documents
AI accelerates. Our experts validate.
Every output goes through expert medical review before it reaches your team. AI handles structure and speed — we handle scientific judgement and MLR readiness.
// Query: systematic review immunotherapy combinations 2023–24
search("publication systematic review oncology", {
years: [2023, 2024],
output: "structured_table"
})
// 4,200 records → 67 relevant
Processing 4,200 records...
Literature Landscape
67 systematic reviews on IO combinations (2023–24). Gap: no published meta-analysis on IO+IO vs IO+chemo in 1L NSCLC with PD-L1 ≥50%. Publication opportunity...